Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-14 Purchase |
2025-02-19 5:44 pm |
Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner |
1,250,000 | $16 | $20,000,000 | 958,412 (Indirect) |
View |
| 2025-02-14 Purchase |
2025-02-19 4:35 pm |
Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner |
16,542 | $16 | $264,672 | 2,970,203 (Indirect Direct) |
View |
| 2025-02-14 Purchase |
2025-02-19 4:30 pm |
Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer |
10,000 | $16 | $160,000 | 99,484 (Direct) |
View |
| 2025-02-14 Purchase |
2025-02-19 4:02 pm |
Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua Former 10% Owner |
187,500 | $16 | $3,000,000 | 987,689 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Conversion |
2025-02-19 5:44 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner |
25,269,999 | $0 | 958,412 (Indirect) |
View |
| 2025-02-14 Conversion |
2025-02-19 4:57 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Chi Jeffrey Director |
1,263,499 | $0 | 133,364 (Indirect) |
View |
| 2025-02-14 Conversion |
2025-02-19 4:48 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Vickers Venture Fund VI Pte Ltd 10% Owner |
19,430,250 | $0 | 2,050,902 (Indirect) |
View |
| 2025-02-14 Conversion |
2025-02-19 4:35 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner |
391,305 | $0 | 2,970,203 (Direct) |
View |
| 2025-02-14 Conversion |
2025-02-19 4:30 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer |
66,333 | $0 | 99,484 (Direct) |
View |
| 2025-02-14 Conversion |
2025-02-19 4:02 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua Former 10% Owner |
7,580,999 | $0 | 987,689 (Indirect) |
View |
Ownership |
2025-02-12 7:47 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner |
0 | $0 | 2,667,299 (Indirect) |
View |
Ownership |
2025-02-12 7:24 pm |
N/A 2030-12-08 |
Aardvark Therapeutics Inc. | AARD | Jones Bryan Chief Operating Officer |
0 | $0 | 118,006 (Direct) |
View |
Ownership |
2025-02-12 7:24 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer |
0 | $0 | 113,203 (Direct) |
View |
Ownership |
2025-02-12 7:19 pm |
N/A 2034-12-17 |
Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director |
0 | $0 | 29,502 (Direct) |
View |
Ownership |
2025-02-12 7:17 pm |
N/A 2034-11-13 |
Aardvark Therapeutics Inc. | AARD | Graf Susan E Director |
0 | $0 | 29,502 (Direct) |
View |
Ownership |
2025-02-12 7:11 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Vickers Venture Fund VI Pte Ltd 10% Owner |
0 | $0 | 2,050,902 (Indirect) |
View |
Ownership |
2025-02-12 7:07 pm |
N/A 2034-08-31 |
Aardvark Therapeutics Inc. | AARD | Jaiman Manasi Chief Medical Officer |
0 | $0 | 177,012 (Direct) |
View |
Ownership |
2025-02-12 6:55 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Chi Jeffrey Director |
0 | $0 | 133,364 (Indirect) |
View |
Ownership |
2025-02-12 6:49 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner |
0 | $0 | 3,012,665 (Direct) |
View |
Ownership |
2025-02-12 5:18 pm |
N/A N/A |
Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua 10% Owner |
0 | $0 | 6,780,810 (Indirect) |
View |